Glaucoma research grants awarded

Article

The International Glaucoma Association (IGA) will be awarding five grants totaling ?255 000 for critical glaucoma research.

The International Glaucoma Association (IGA) will be awarding five grants totaling £255 000 for critical glaucoma research.

Increased by 60% since last year, the grants will be awarded to professionals specializing in glaucoma research and patient care. This will include a grant of £90 000 for the Royal College of Ophthalmology joint award, £90 000 for the UK and Eire Glaucoma Society joint award, £30 000 for the IGA and College of Optometrists award, £30 000 for the Royal College of Nursing award and £15 000 for the Fight for Sight glaucoma research award.

Russell Young, CEO of the IGA, commented, “Since IGA was first formed in 1974, research has been central to our work. We are committed to supporting the many professionals who work tirelessly to investigate, manage and care for people with glaucoma."

"It is this work that enables us to provide accurate, evidence-based support and information to people living with glaucoma and to realise that much more needs to be done to reach the 300 000 people who have yet to be diagnosed, and are at serious risk of vision loss."

For further details about the awards and a list of deadlines please click here.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.